Amy Jones
Women's Health · Montgomery, ALNPI 1528690542
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 55 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Sumitomo Pharma America, Inc. at 26.2% of the total. 2025 is the largest year on record at $377, 2.6 times the $145 reported in 2022.
Across 55 payments — averaging $19.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sumitomo Pharma America, Inc.$275
- Astellas Pharma US Inc$141
- BD$110
- AbbVie$101
- Hologic Sales And Service, LLC$70
- Pfizer$55
- plus $298 from 10 others
What the payments were for
- Food & beverage$1,051100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sumitomo Pharma America, Inc. | 17 | $275 |
| Astellas Pharma US Inc | 7 | $141 |
| BD | 3 | $110 |
| AbbVie | 5 | $101 |
| Hologic Sales And Service, LLC | 4 | $70 |
| Pfizer | 3 | $55 |
| Sage Therapeutics, LLC | 3 | $49 |
| Pharmacosmos Therapeutics Inc. | 2 | $48 |
| Vertex | 2 | $45 |
| Dexcom, Inc. | 2 | $41 |
| Mayne Pharma Commercial LLC | 2 | $30 |
| Myovant Sciences Inc. | 1 | $20 |
| Scynexis, Inc. | 1 | $19 |
| Medtronic | 1 | $19 |
| Shield Therapeutics Inc | 1 | $15 |
| Avion Pharmaceuticals | 1 | $12 |
How this compares
$1,051 in reported general payments places this provider in the 65th percentile of 107 women's health providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 32 | $4,509 |
| Estradiol | 74 | $3,672 |
| ValacyclovirValacyclovir Hcl | 25 | $2,423 |
| Clobetasol Propionate | 21 | $877 |
| Fluconazole | 61 | $461 |
| Metronidazole | 35 | $350 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 13 | $170 |
| Doxycycline Hyclate | 19 | $150 |
| Nystatin | 16 | $137 |
Paid to pharmacies, not to this prescriber.
Other women's health in Montgomery
- Terri SingletaryMontgomery$1K
- Cortney PettyMontgomery$1K
- Hannah EdwardsMontgomery$725
- Brooke WattsMontgomery$708
- Maegan AllenMontgomery$505
- Ashton TureaudBirmingham$26K
- Mary MatteiMobile$10K
- Kathryn LyleBirmingham$7K
- Tracy BrownFoley$6K
- Kimberly PeekHuntsville$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.